The Limited Times

Now you can see non-English news...

Denmark Suspends AstraZeneca Vaccine Use; this is the reason

2021-03-11T11:10:30.398Z


Denmark suspended use of the Oxford-AstraZeneca covid-19 vaccine for 14 days while investigating reports of some patients developing blood clots after being inoculated.


What do vaccines for covid-19 contain?

An expert answers 6:19

(CNN) -

Denmark suspended use of the Oxford-AstraZeneca covid-19 vaccine for 14 days while investigating reports of some patients developing blood clots after being inoculated.

This comes days after several other European Union (EU) countries discontinued use of a specific lot of the vaccine.

The Danish Medicines Agency, "in collaboration with the European Medicines Agency (EMA) and the other pharmaceutical authorities of the EU, has launched an investigation into the AstraZeneca vaccine following reports of blood clots in citizens who have received the vaccine" .

  • Pfizer and AstraZeneca vaccines against coronavirus are highly effective in preventing severe cases, according to two studies

"One report relates to a death in Denmark," said a statement from the Danish Medicines Agency on Thursday.

"We still don't know if the blood clots and the Danish death are due to the vaccine, but now it needs to be thoroughly examined for safety," said Tanja Erichsen, unit director of the Danish Medicines Agency.

advertising

Earlier this week, Austria suspended the use of a specific batch of AstraZeneca's vaccine, batch ABV5300, after "a person was diagnosed with multiple thrombosis," according to the EU drug regulator EMA.

Medical staff prepare a syringe for the AstraZeneca vaccine at the Hovedstaden Region vaccination center, Bella Center, in Copenhagen on February 11, 2021. (Photo by LISELOTTE SABROE / Ritzau Scanpix / AFP via Getty Images)

As of Tuesday, Estonia, Lithuania, Luxembourg and Latvia had also suspended the use of the ABV5300 lot.

It has not been specified whether the Danish death was related to this lot.

  • This is how second-generation vaccines are prepared to combat variants of the new coronavirus

On Wednesday, the EMA said that "there is currently no indication that vaccination has caused these conditions, which are not listed as side effects of this vaccine."

"The ABV5300 lot was delivered to 17 EU countries and comprises 1 million doses of the vaccine," the EMA said in a statement.

'Some EU countries have also subsequently suspended this batch as a precautionary measure, while a full investigation is under way.

The quality defect is considered unlikely at this stage, the quality of the batch is being investigated. '

AstraZenecaCoronavirus Vaccine

Source: cnnespanol

All news articles on 2021-03-11

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.